- Home
- QSI vs SCPH Comparison
QSI vs SCPH Comparison
Compare QSI & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QSI
- SCPH
- Stock Information
- Founded
- QSI 2013
- SCPH 2013
- Country
- QSI United States
- SCPH United States
- Employees
- QSI N/A
- SCPH N/A
- Industry
- QSI Biotechnology: Pharmaceutical Preparations
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- QSI Health Care
- SCPH Health Care
- Exchange
- QSI Nasdaq
- SCPH Nasdaq
- Market Cap
- QSI N/A
- SCPH 173.6M
- IPO Year
- QSI N/A
- SCPH 2017
- Fundamental
- Price
- QSI $1.20
- SCPH $2.63
- Analyst Decision
- QSI Strong Buy
- SCPH Strong Buy
- Analyst Count
- QSI 3
- SCPH 3
- Target Price
- QSI $3.42
- SCPH $14.00
- AVG Volume (30 Days)
- QSI 8.8M
- SCPH 624.1K
- Earning Date
- QSI 03-03-2025
- SCPH 03-19-2025
- Dividend Yield
- QSI N/A
- SCPH N/A
- EPS Growth
- QSI N/A
- SCPH N/A
- EPS
- QSI N/A
- SCPH N/A
- Revenue
- QSI $3,058,000.00
- SCPH $36,332,000.00
- Revenue This Year
- QSI $157.33
- SCPH $134.20
- Revenue Next Year
- QSI $174.05
- SCPH $99.40
- P/E Ratio
- QSI N/A
- SCPH N/A
- Revenue Growth
- QSI 182.63
- SCPH 167.28
- 52 Week Low
- QSI $0.61
- SCPH $2.50
- 52 Week High
- QSI $5.77
- SCPH $5.65
- Technical
- Relative Strength Index (RSI)
- QSI 37.57
- SCPH 30.22
- Support Level
- QSI $1.36
- SCPH $2.87
- Resistance Level
- QSI $1.54
- SCPH $3.08
- Average True Range (ATR)
- QSI 0.12
- SCPH 0.19
- MACD
- QSI 0.01
- SCPH -0.02
- Stochastic Oscillator
- QSI 12.50
- SCPH 18.84
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.